Ake­bia adds $50M deal with Vi­for for ex­clu­sive US dis­tri­b­u­tion deal for vadadu­s­tat

Ake­bia keeps stack­ing up the mon­ey deals for its close­ly-watched ane­mia drug.

In the lat­est deal an­nounced af­ter the mar­ket closed Mon­day, Vi­for Phar­ma said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.